Medical brain–machine interface developer Weiling Medical has closed a financing round of more than RMB100 million led by Junzhong Capital, with Innotech as the fund’s core industrial investor. Proceeds will be used to advance clinical validation of implantable BMI core products, speed medical-device registration, expand manufacturing capacity and broaden clinical applications in neurofunctional rehabilitation.

2026-08-17

Medical brain–machine interface developer Weiling Medical has closed a financing round of more than RMB100 million led by Junzhong Capital, with Innotech as the fund’s core industrial investor. Proceeds will be used to advance clinical validation of implantable BMI core products, speed medical-device registration, expand manufacturing capacity and broaden clinical applications in neurofunctional rehabilitation.